Philips initiated a voluntary recall for some of its sleep apnea machines and ventilators. The American multinational conglomerate company cited concerns for a foam component that may get detached or degrade and become toxic when inhaled by the user.
It was said that if such a thing happens, there is a possibility it could cause health issues including the development of cancer due to toxic and carcinogenic effects. To prevent this and protect the users, Philips issued a recall notification on Monday, June 14.
The affected devices and Philips’ announcement
As per Fox Business, the Philips recall will affect three to four million units of certain machine models that feature Bi-Level Positive Airway Pressure (Bi-Level PAP), Continuous Positive Airway Pressure (CPAC) and the mechanical ventilator machines. It was revealed that the company already issued the first warning over the issue in April.
Philips announced its voluntary recall notification after consulting with regulatory agencies. The company said that with the recalled products, the company will immediately take corrective actions that include the distribution of updated instructions for the repair and replacement of the affected items. As of this time, Philips is continuously monitoring reports of safety issues and so far, it has not received any reports of death due to the product issues.
It was added that due to potential risks of exposure, users may experience headaches, respiratory issues, irritation, inflammation and possible toxic or carcinogenic effects. But fortunately, there is no report of these effects yet related to chemical emissions.
“We deeply regret any concern and inconvenience that patients using the affected devices will experience because of the proactive measures we are announcing today to ensure patient safety,” Philips CEO, Frans van Houten, said in a press release. “In consultation with the relevant regulatory agencies and in close collaboration with our customers and partners, we are working hard towards a resolution. Patient safety is at the heart of everything we do at Philips.”
How Philips will solve the issue
Reuters reported that Philips is now working with the health authorities and regulators for the safety of the consumers. It is looking for a way for the safe replacement of the foam that may potentially become toxic and cause cancer.
It was added that Philips is not conducting tests and it needs to get good results so it can pass the regulatory requirements. The company will also be replacing the products that cannot be repaired or updated.


SK Hynix, Samsung Lead Asian Chip Stock Selloff After Sandisk, Western Digital Outlook
Daimler Truck Q2 Profit Falls 18%, 2026 Outlook Raised
Cloudflare Stock Jumps 15% as Earnings Beat Estimates, 2026 Outlook Raised
Heineken H1 Operating Profit Meets Forecast as Beer Volumes Beat Expectations
Oil Prices Slip as Hormuz Shipping Progress and Rising U.S. Crude Stocks Weigh on Market
Oil Prices Set for Steep Weekly Losses as Hormuz Deal Stalls
Asian Currencies Steady as Markets Await U.S. Jobs Data
Dollar Holds Near Six-Week Low as Yen Loses Momentum Ahead of U.S. Jobs Data
Airbnb Stock Jumps After Q2 Earnings Beat, Strong 2026 Outlook
US Stock Futures Rise as Markets Await July Payrolls Data
Singapore Says One-Third of U.S. Exports Hit by New 12.5% Tariff
Meta Ordered to Pay $567M Over Child Safety Violations in New Mexico
SoftBank Q1 Profit Beats Forecast as Intel Rally and OpenAI Investments Boost Returns
DBS Raises 2025 Outlook After Record Q2 Profit Driven by Wealth Management
Sinopec Boosts Russian ESPO Oil Purchases as Middle East Supply Tightens
Nvidia Seen Beating Q2 Targets as Vera Rubin Cycle Begins
Alibaba Plans Revenue-Sharing Model for Qwen3.8-Max AI Commercial Users 



